Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Claudia Ana Burillo Vargas

Claudia Ana Burillo Vargas

Institutions of which they are part

Liver Diseases
Vall Hebron Institut de Recerca
Claudia Ana Burillo Vargas

Claudia Ana Burillo Vargas

Claudia Ana Burillo Vargas

Institutions of which they are part

Liver Diseases
Vall Hebron Institut de Recerca

Related news

Grup de Malalties Hepàtiques del VHIR

A clinical trial has led to approval of the first drug for advanced fatty liver disease

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

Equip projecte ARTEMIs

We study fatty liver and cardiovascular complications with digital twins

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

Les Drs. María Martell i Ibane Abasolo

New treatment based on nanoparticles for chronic liver disease

The research team used nanotechnology to deliver the drug directly to liver cells, which eliminated side effects without reducing effectiveness.

See more

Related professionals

Anna Penalba Morenilla

Anna Penalba Morenilla

Main researcher
Neurovascular Diseases
Read more
Alba Mir Cros

Alba Mir Cros

Postdoctoral researcher
Microbiology
Read more
Gabriel Sampol Rubio

Gabriel Sampol Rubio

Pneumology
Read more
Vicente Serra García

Vicente Serra García

Cardiovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.